Michael D. Nailor

1.4k total citations
62 papers, 956 citations indexed

About

Michael D. Nailor is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Michael D. Nailor has authored 62 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 25 papers in Infectious Diseases and 13 papers in Molecular Medicine. Recurrent topics in Michael D. Nailor's work include Antibiotic Resistance in Bacteria (13 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Antifungal resistance and susceptibility (11 papers). Michael D. Nailor is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Antifungal resistance and susceptibility (11 papers). Michael D. Nailor collaborates with scholars based in United States, Saudi Arabia and Belgium. Michael D. Nailor's co-authors include Kellie J. Goodlet, David P. Nicolau, Jack D. Sobel, Joseph L. Kuti, Sofya Tokman, Natalie K. Boyd, Sunwen Chou, Jaber Aslanzadeh, Spencer T. Martin and Emily L. Heil and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Michael D. Nailor

60 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Nailor United States	19	489	247	233	191	177	62	956
B. Pilmis France	20	498 1.0×	339 1.4×	324 1.4×	156 0.8×	156 0.9×	85	1.1k
Béatrice Grabein Germany	14	425 0.9×	255 1.0×	263 1.1×	124 0.6×	261 1.5×	42	921
Daniel Curcio United States	16	436 0.9×	265 1.1×	226 1.0×	123 0.6×	158 0.9×	50	866
Sercan Ulusoy Türkiye	20	630 1.3×	241 1.0×	358 1.5×	150 0.8×	139 0.8×	75	1.2k
Marinês Dalla Valle Martino Brazil	15	371 0.8×	238 1.0×	283 1.2×	205 1.1×	122 0.7×	55	873
Hyun Kyun Ki South Korea	17	482 1.0×	243 1.0×	341 1.5×	160 0.8×	117 0.7×	45	1.0k
Cheston B. Cunha United States	16	286 0.6×	279 1.1×	128 0.5×	164 0.9×	125 0.7×	41	880
Grace C. Lee United States	17	328 0.7×	339 1.4×	271 1.2×	201 1.1×	152 0.9×	41	1.1k
Jin-Won Chung South Korea	18	446 0.9×	526 2.1×	333 1.4×	156 0.8×	151 0.9×	70	1.2k
Rupali Jain United States	17	419 0.9×	412 1.7×	335 1.4×	144 0.8×	322 1.8×	55	1.1k

Countries citing papers authored by Michael D. Nailor

Since Specialization

Citations

This map shows the geographic impact of Michael D. Nailor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Nailor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Nailor more than expected).

Fields of papers citing papers by Michael D. Nailor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Nailor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Nailor. The network helps show where Michael D. Nailor may publish in the future.

Co-authorship network of co-authors of Michael D. Nailor

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Nailor. A scholar is included among the top collaborators of Michael D. Nailor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Nailor. Michael D. Nailor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goodlet, Kellie J., Michael D. Nailor, & Sofya Tokman. (2025). P-2274. Incidence and Microbiology of Postoperative Pleural Space Infections among Lung Transplant Recipients. Open Forum Infectious Diseases. 12(Supplement_1).

Ahmad, Shoaib, R. Curtis Bay, Michael D. Nailor, et al.. (2025). Kaposi sarcoma in lung transplant recipients with public health service increased-risk donors: A retrospective cohort study and review of the literature. JHLT Open. 11. 100468–100468.

Nailor, Michael D., et al.. (2024). Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients. Transplant Infectious Disease. 26(3). e14279–e14279. 5 indexed citations

Nailor, Michael D., et al.. (2022). Adherence and outcomes of a surgical prophylaxis guideline promoting cephalosporin use among patients with penicillin allergy. Surgery. 172(6). 1598–1603. 6 indexed citations

Goodlet, Kellie J., et al.. (2021). Impact of the FilmArray meningitis/encephalitis panel on antimicrobial duration among patients with suspected central nervous system infection. Diagnostic Microbiology and Infectious Disease. 100(4). 115394–115394. 12 indexed citations

Radosevich, John, et al.. (2021). Narrowing antibiotic spectrum of activity for trauma-associated pneumonia through the use of a disease-specific antibiogram. Trauma Surgery & Acute Care Open. 6(1). e000602–e000602. 1 indexed citations

Goodlet, Kellie J., et al.. (2018). Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection. American Journal of Transplantation. 18(12). 3060–3064. 98 indexed citations

Goodlet, Kellie J., et al.. (2018). Evaluation of a best practice alert to reduce unnecessary Clostridium difficile testing following receipt of a laxative. Diagnostic Microbiology and Infectious Disease. 92(1). 50–55. 18 indexed citations

Goodlet, Kellie J. & Michael D. Nailor. (2017). Necessity of carbapenem use when prescribed per infectious diseases specialists. Diagnostic Microbiology and Infectious Disease. 88(1). 41–46. 4 indexed citations

10.

Ghazi, Islam M., David P. Nicolau, Michael D. Nailor, et al.. (2016). Antibiotic Utilization and Opportunities for Stewardship Among Hospitalized Patients With Influenza Respiratory Tract Infection. Infection Control and Hospital Epidemiology. 37(5). 583–589. 19 indexed citations

11.

Crandon, Jared L., et al.. (2016). Evaluation of a disease state management guideline for urinary tract infection. International Journal of Antimicrobial Agents. 47(6). 451–456. 3 indexed citations

12.

Nicolau, David P., et al.. (2015). Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics. Infection and Drug Resistance. 8. 297–297. 45 indexed citations

13.

Kuti, Joseph L., et al.. (2014). Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae. Scandinavian Journal of Infectious Diseases. 46(11). 803–808. 20 indexed citations

14.

Nailor, Michael D., et al.. (2013). Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures*. Critical Care Medicine. 41(7). 1656–1663. 57 indexed citations

15.

Nailor, Michael D. & Jack D. Sobel. (2011). Antibiotics for Gram-Positive Bacterial Infection: Vancomycin, Teicoplanin, Quinupristin/Dalfopristin, Oxazolidinones, Daptomycin, Telavancin, and Ceftaroline. Medical Clinics of North America. 95(4). 723–742. 9 indexed citations

16.

Boyd, Natalie K. & Michael D. Nailor. (2011). Combination Antibiotic Therapy for Empiric and Definitive Treatment of Gram‐Negative Infections: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(11). 1073–1084. 43 indexed citations

17.

Nailor, Michael D. & Jack D. Sobel. (2009). Antibiotics for Gram-Positive Bacterial Infections: Vancomycin, Teicoplanin, Quinupristin/Dalfopristin, Oxazolidinones, Daptomycin, Dalbavancin, and Telavancin. Infectious Disease Clinics of North America. 23(4). 965–982. 36 indexed citations

18.

Nailor, Michael D. & Pranatharthi Chandrasekar. (2009). Antifungal drugs: predicting clinical efficacy with pharmacodynamics. Expert Review of Clinical Pharmacology. 2(4). 373–379. 3 indexed citations

19.

Nailor, Michael D.. (2008). Daptomycin (DAP) for Methicillin Resistant Staphylococcus aureus bacteremia (MRSA) with Elevated Vancomycin Minimum Inhibitor Concetrations (MICs). 46th Annual Meeting. 1 indexed citations

20.

Nailor, Michael D. & Jack D. Sobel. (2007). Tinidazole for the treatment of vaginal infections. Expert Opinion on Investigational Drugs. 16(5). 743–751. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact